RANDOMIZED STUDY OF PHASE III WITH RADIOTHERAPY IN PATIENTS MASTECTOMIZED BY BREAST CANCER OF CLINICAL STAGE II, WITH ONE TO THREE POSITIVE GANGLES
Not Applicable
- Conditions
- -C50 Malignant neoplasm of breastMalignant neoplasm of breastC50
- Registration Number
- PER-076-03
- Lead Sponsor
- EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG),
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients should be women with breast adenocarcinoma,
histologically confirmed, with a primary tumor of <5 cm and 1-3 positive axillary lymph nodes. Patients with positive lymph nodes only by cytokeratin staining and negative with hematoxylin-eosin are not eligible.
Patients must not have received Trastuzumab previously.
Exclusion Criteria
underage
pregnant women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br>Outcome name:not contemplated<br>Measure:not contemplated<br>Timepoints:not contemplated<br>
- Secondary Outcome Measures
Name Time Method <br>Outcome name:not contemplated<br>Measure:not contemplated<br>Timepoints:not contemplated<br>